Oligoarthritis: Causes and Treatment

Oligoarthritis is an inflammatory arthritis in which one to four joints are simultaneously affected. The term describes a clinical pattern rather than a specific disease: it can encompass a variety of entities, from peripheral spondyloarthritides (including psoriatic arthritis) to reactive, crystal-induced, septic arthritis, and the childhood variant, oligoarticular juvenile idiopathic arthritis (JIA). Proper management is based not on a "label," but on a step-by-step search for the cause and risk assessment, including infectious ones. [1]

In adults, asymmetric oligoarthritis often indicates a spectrum of spondyloarthritis—psoriatic arthritis (PsA) and peripheral spondyloarthritis (pSpA). The oligoarticular variant is classically described for PsA; it is common at initial onset and can eventually progress to polyarthritis if inflammation is not controlled. Therefore, early risk stratification and a treat-to-target strategy are essential. [2]

In children, oligoarticular JIA is the most common subtype of JIA, typically onset in preschool-aged girls; vigilance for uveitis and vision monitoring are important. Diagnosis in children is established according to the ILAR/PRINTO criteria (≥6 weeks of arthritis, onset before age 16) with subsequent verification of the subtype—"persistent" and "extended" (transition to involvement of ≥5 joints after 6 months). [3]

Finally, oligoarthritis is a typical manifestation of an infectious process: gonococcal, staphylococcal, and streptococcal arthritis can affect two or three joints. In this case, any delay in puncture and antibiotics increases the risk of destruction. Therefore, arthrocentesis with synovial fluid analysis plays a key role in the diagnostic algorithm. [4]

Code according to ICD-10 and ICD-11

Adult "oligoarthritis as such" is usually coded in the ICD based on the underlying nosology. For example, for psoriatic arthritis, ICD-10-CM L40.5- (arthropathic psoriasis) is used, with variant specifications (L40.51 - distal; L40.52 - mutilans; L40.53 - spondylitis; L40.50 - unspecified). For children with JIA, separate codes are available: M08.40 and others for pauci-/oligoarthritis. [5]

In ICD-11, PsA is classified as block FA21 (with subtypes including FA21.0 "psoriatic spondyloarthritis"), while the juvenile oligoarthritic form is classified as block FA24.0 (persistent/extended). ICD-11 allows for post-coordination—the anatomy of specific joints and side can be added, which improves the analytical capabilities of the data. [6]

If the cause is unclear, "other/unspecified arthritis" codes are acceptable (e.g., M13.8x/M13.89 in ICD-10-CM), but their use is recommended temporarily while differential diagnosis is underway. After the cause is verified, the code should be refined (PsA, reactive arthritis, crystal-induced, septic, etc.). [7]

For episodes of septic oligoarthritis, infection and pathogen codes are added; for reactive arthritis, a trigger infection code (e.g., urogenital/enteric) is added. Correct coding affects routing, pricing, and surveillance. [8]

Table 1. Examples of coding (adults/children)

Situation	ICD-10-CM	ICD-11
Psoriatic arthritis with oligoarthritis clinical features	L40.5x (variants)	FA21 (specify subtype/anatomy)
JIA, oligoarthritis	M08.40 and others.	FA24.0x (persistent/extended)
"Oligoarthritis, unspecified" at the start	M13.8x/M13.89	temporary cluster codes, then clarification
Septic oligoarthritis	M00.x + B95-B96 (pathogen)	FB21.x + XE exciter codes [9]

Epidemiology

In adults, the most common inflammatory "source" of oligoarthritis is spondyloarthritis, particularly PsA and pSpA. For PsA, the oligoarticular pattern is one of the dominant ones at onset; the proportion varies across different cohorts, but oligoarthritis is recognized as a typical "entry" into the disease. Over time, some patients progress to polyarthritis if treatment is delayed. [10]

In children, oligoarticular JIA is the most common subtype: in recent cohorts, it accounts for approximately 40-50% of all cases of JIA. Onset is typically between 1 and 6 years of age and female gender; transition to an "extended" variant (≥5 joints after 6 months) is possible. The population prevalence of JIA as a whole is tens of per 100,000; the variation is due to the recording methods. [11]

In the structure of septic arthritis, oligoarthritis is less common than monoarthritis, but it is significant: in adults, 2-3 large joints may be affected; gonococcal infection results in migratory oligoarthritis/tenosynovitis. This is important because the outcome directly depends on the speed of puncture and the initiation of antibiotics. [12]

For PsA, the general population prevalence is estimated at 0.3-1%, and among patients with psoriasis it is significantly higher; this is why, when people with psoriasis present with joint complaints, signs of oligoarthritis, enthesitis and dactylitis should be specifically sought. [13]

Reasons

1. Peripheral spondyloarthritides: psoriatic arthritis (associated with cutaneous/nail psoriasis, dactylitis, enthesitis, sacroiliitis) and peripheral SpA (often HLA-B27-associated). For pSpA, the ASAS criteria apply; the clinical picture often begins as oligoarthritis of the lower extremities. [14]
2. Reactive arthritis following urogenital (Chlamydia trachomatis, Neisseria gonorrhoeae) or enteral infections (Salmonella, Shigella, Campylobacter): asymmetric oligoarthritis with enthesitis, sometimes conjunctivitis/uveitis. If a trigger is identified, etiotropic antibacterial therapy is recommended. [15]
3. Crystal-induced arthritis (gout/CPPD): may present as a relapsing oligoarthritis, especially in the elderly and with comorbidity; diagnosis is confirmed by polarized microscopy of urate/pyrophosphate crystals. [16]
4. Septic arthritis: most often mono-, but oligoarthritis (2-3 joints) is possible, including gonococcal; requires immediate puncture and antibiotics according to guidelines. [17]

Risk factors

In PsA - psoriasis of the skin/nails, family history, metabolic factors; in pSpA/reactive arthritis - HLA-B27 and previous infections (urogenital/enteral). Trauma, smoking and obesity are associated with a more active course and a worse response to therapy. [18]

For JIA oligoarthritis, female gender and early age of onset are considered factors; the risk of uveitis is higher in ANA positivity, so ophthalmological screening is mandatory. [19]

For septic oligoarthritis, immunosuppression, joint replacement, injection procedures, skin infections, and bacteremia are considered. Any acutely inflamed joint with fever is a reason to rule out infection first. [20]

Crystalline oligoarthritis is promoted by hyperuricemia, chronic kidney disease, diuretics, and a high-purine diet/alcohol. Identification of modifiable factors is part of relapse prevention. [21]

Pathogenesis

In spondyloarthritis, key features include enthesitis and immune inflammation at the bone-tendon interface involving the IL-23/IL-17 and TNF-α pathways; in PsA, dactylitis and osteitis are also present, explaining the localized painful swelling of finger segments and asymmetric oligoarthritis. These insights form the basis for targeted therapy (TNF, IL-17, IL-23, and JAK inhibitors). [22]

Reactive arthritis is triggered by a post-infectious immune response; bacterial antigens can persist in the synovium, sustaining inflammation, especially in HLA-B27 carriers. Etiotropic antibiotics are effective in the presence of an active urogenital infection trigger. [23]

Crystal-induced arthritis is caused by monosodium urate/CPPD crystals activating the NLRP3 inflammasome and the release of IL-1β; hence the effectiveness of colchicine and IL-1 inhibitors in patients resistant to standard therapy. [24]

Septic arthritis is a direct invasion of the microbe into the joint cavity with neutrophilic exudate, rapid damage to cartilage and the risk of destruction; hence the priority of urgent puncture/drainage and antibiotics. [25]

Symptoms

The main symptoms are pain, swelling, morning stiffness for >30-60 minutes, and limited range of motion. Asymmetrical involvement of the knees/metatarsophalangeal joints, enthesitis (in the heel area), and dactylitis (sausage toe) are typical of spondyloarthritis. In PsA, attention is paid to nail changes (pitting, onycholysis) and skin psoriasis. [26]

Reactive arthritis begins 1-6 weeks after infection, often with conjunctivitis, dysuria/urethritis, and spotty rashes on the soles/palms. Stiffness and pain worsen at night and subside during the day. [27]

Crystalline oligoarthritis is characterized by acute attacks of multiple joints with severe redness and pain, sometimes with fever; remission occurs between attacks. The diagnosis is confirmed by the presence of crystals in the synovium. [28]

The septic variant has an acute onset, fever, severe pain, and severe limitation; sometimes 2-3 joints are affected. Any "inflamed" joint with systemic signs is an indication for urgent puncture. [29]

Forms and stages

Clinically, there are inflammatory non-infectious oligoarthritis (PsA/pSpA, reactive, crystalline) and infectious oligoarthritis (septic, including gonococcal). By time - acute (days-weeks), subacute, chronic/recurrent. For JIA - "persistent" and "extended" subtypes. [30]

The dynamics of the course are important for the strategy: in spondyloarthritis, targeted activity control according to scales with regular reassessment; in crystalline forms, control of attacks and urate-lowering therapy; in reactive forms, eradication of the trigger infection. [31]

In PsA, some patients "expand" the number of affected joints over time; early targeted therapy reduces the risk of progression and damage. In children, the transition to "extended" JIA oligoarthritis increases the need for biologics. [32]

Septic oligoarthritis requires immediate "aggressive" treatment: puncture, drainage, empirical antibiotics followed by de-escalation and re-sanitation. [33]

Table 2. Ethical "clusters" of oligoarthritis

Cluster	Tips	First steps
PsA / pSpA	Psoriasis, dactylitis, enthesitis, HLA-B27	NSAIDs → csDMARD (peripheral) → b/tsDMARD
Reactive	Recent STI/enteritis	PCR/cultures, NSAIDs, antibiotics for active infection
Crystal	Paroxysmal, hyperuricemia, crystals	Arthrocentesis, NSAIDs/CS/colchicine, ULT
Septic	Fever, acute, ↑CRP, risk of ischemic stroke	Puncture, drainage, antibiotics immediately [34]

Complications and consequences

Without treatment, inflammatory oligoarthritis leads to structural damage (erosions, osteitis), decreased function, and decreased quality of life. PsA also causes skin/nail problems and comorbidity (metabolic syndrome), requiring a multidisciplinary approach. [35]

In children, there is a risk of "extending" and sight-threatening uveitis; regular ophthalmologic examinations are vital. Early access to biological therapy improves growth and functional outcomes. [36]

Crystalline oligoarthritis without urate control leads to tophi and chronic joint/tendon damage. Septic oligoarthritis is dangerous due to cartilage destruction and sepsis; the prognosis is directly related to the speed of initiation of debridement and antibacterial therapy. [37]

Psychological burden (pain, fatigue) is significant; current recommendations specifically emphasize monitoring of fatigue and patient involvement in shared decision-making. [38]

Diagnostics

1. Clinical presentation and screening questions: psoriasis in patient/relative, heel pain (enthesitis), sausage-shaped fingers (dactylitis), inflammatory back pain, recent STI/enteritis, paroxysmal (crystal), fever/chills (infection).
2. Laboratory: CBC, CRP/ESR, rheumatoid factor and anti-CCP (to exclude RA), HLA-B27 (if SpA is suspected), uric acid (screening), PCR/cultures from the urogenital tract/stool if reactive arthritis is suspected.
3. Arthrocentesis is the key: total and differential leukocyte count, Gram stain/culture, crystals (polarizing microscopy), glucose, and protein. For septic arthritis in adults, optimal synovial WBC thresholds depend on previous antibiotic therapy: ≈>33,000/μL (without antibiotics) and ≈>16,000/μL (after) improve diagnostic accuracy. In crystalline arthritis, crystals are decisive. [39]
4. Visualization: X-ray - basic (erosions, osteoperistosis, calcifications); high-resolution ultrasound with Power Doppler reveals synovitis and enthesitis, can be safely repeated; MRI - in controversial cases and early changes (ostitis, sacroiliitis/enthesitis, "bone marrow edema"). Current European guidelines emphasize the role of ultrasound/MRI for early diagnosis and stratification. [40]

Table 3. Synovial fluid: interpretation guidelines

Category	Leukocytes (/μl)	What are we looking for?	Comments
Non-inflammatory	<2,000	Crystals?	More often mechanics/OA
Inflammatory	2,000-50,000	Crystals, culture	Spondyloarthritis, gout, CPPD
Infectious (without AB)	>33,000	Gram/culture + clinical examination	The most accurate threshold is in adults
Infectious (after AB)	>16,000	As above	The threshold is lowered due to the AB effect [41]

Differential diagnosis

Spondyloarthritis vs. rheumatoid arthritis: SpA is characterized by asymmetric oligoarthritis, enthesitis/dactylitis, often HLA-B27, and often psoriasis/ischemic arthritis; RA is characterized by symmetric polyarthritis of the small joints of the hands, often anti-CCP positivity. Ultrasound/MRI are helpful: SpA is characterized by enthesitis and osteitis. [42]

Crystalline vs. septic: Both can be acute and very painful. Arthrocentesis is decisive: urate/CPPD crystals confirm a crystalline process but do not exclude coinfection, so culture is mandatory, especially in febrile conditions. [43]

Reactive vs. PsA/pSpA: reactive is temporally related to infection (1-6 weeks) and has typical extra-articular signs; in PsA, skin/nail psoriasis, family history, and dactylitis are present. If in doubt, the diagnosis is based on the patient's medical history, PCR tests, and the dynamics of the response to therapy. [44]

JIA oligoarthritis vs. septic arthritis in a child: Sepsis is characterized by acute onset, high fever, elevated CRP, and one or more large joints; immediate arthrocentesis and antibiotics are indicated. JIA is characterized by chronic progression, often ANA positivity; ophthalmologic screening is necessary. [45]

Table 4. Who's who in oligoarthritis

Option	Tips	Test solver
PsA/pSpA	Psoriasis, enthesitis, dactylitis, HLA-B27	Ultrasound/MRI of enthesitis, ruling out infection
Reactive	Recent STI/enteritis	PCR/cultures + arthrocentesis
Crystal	Seizures, hyperuricemia	Crystals in synovium
Septic	Fever, acute, high CRP	Puncture, Gram/culture, early AB

Treatment

Immediate decisions are determined by the risk of infection: at the slightest suspicion, arthrocentesis before antibiotics (if possible), then empirical antibiotics and drainage according to current European guidelines; further de-escalation is based on culture. This priority is higher than any anti-inflammatory therapy. [46]

PsA / peripheral SpA (oligoarthritis): first step - NSAIDs and local glucocorticosteroid injections into the affected joints/entheses. In case of insufficient response - csDMARD (methotrexate, sulfasalazine, leflunomide) for the peripheral variant. If the goal (remission/low activity) is not achieved - bDMARD/tsDMARD without a strict priority of the mechanism: TNF inhibitors, IL-17A/A&F, IL-23 (p19)/IL-12/23 (p40), JAK inhibitors; the choice takes into account the skin/enthesitis/axis and safety factors (e.g., caution with JAK in patients with vascular risk factors). The strategy is treat-to-target with regular reassessment. [47]

Reactive arthritis: pain control (NSAIDs, a short course of systemic corticosteroids if necessary), exercise therapy/ergonomics. In cases of identified and persistent urogenital infection, etiotropic antibiotics (e.g., for Chlamydia) are used, which improves outcomes; long-term antibacterial therapy for "sterile" arthritis without active infection is ineffective. In cases of protracted arthritis, a switch to csDMARDs is possible; biological therapy is considered based on individual indications. [48]

Crystalline oligoarthritis: in an acute attack - NSAIDs, colchicine, or GCS (intra-articular/oral with rapid tapering). Interictal - urate-lowering therapy (allopurinol/febuxostat) with titration to target urate (<360 μmol/L; for tophi <300) and prophylaxis with colchicine at the start. In case of resistance and frequent attacks, IL-1 inhibitors are considered. [49]

JIA oligoarthritis: baseline - NSAIDs, intra-articular corticosteroids (often highly effective); in case of expansion/persistence - methotrexate; if unsuccessful - biological drugs (TNF/IL-6 inhibitors, etc.) taking into account the ophthalmological risk. Regular screening for uveitis is mandatory. [50]

Table 5. Stages of therapy for oligoarthritis (adults)

Scenario	1st line	2nd line	3rd line
PsA/pSpA (peripheral)	NSAIDs ± local GCS	csDMARD (MTX/CVD/LEF)	bDMARD/tsDMARD (TNF, IL-17, IL-23, JAK)
Reactive	NSAIDs ± short CS, exercise therapy	Antibiotic for active infection; csDMARD for chronic infection	Biological therapy according to indications
Crystal	NSAIDs/colchicine/GCS	ULT + prevention	IL-1 inhibitors (refractory)
Septic	Puncture/drainage + AB	De-escalation by seeding	Revascularization/surgery for complications [51]

Non-pharmacology and monitoring: patient education, weight management, smoking cessation, graded activity, range-of-motion and strength training, and gentle ergonomics. Monitoring includes clinical indices, CRP/ESR, and ultrasound/Doppler if necessary (especially for enthesitis). [52]

Prevention

Prevention of secondary episodes depends on the cause. For crystalline arthritis, this includes urate control, alcohol and purine restriction, and diuretic adjustments; for reactive arthritis, this includes safe sexual behavior, prompt treatment of STIs, and food and water hygiene to reduce the risk of enteritis. [53]

For PsA/pSpA, weight management, psoriasis treatment, and early consultation with a rheumatologist for new joint/enthesis symptoms and dactylitis are recommended. Regular physical activity and strength training with gradual increases in load improve function and reduce the risk of inflammation "spreading." [54]

Forecast

Prognosis is determined by the etiology and promptness of treatment initiation. In PsA/pSpA, early treat-to-target therapy (including b/tsDMARDs) allows for remission/low activity, prevents damage, and improves quality of life; delay increases the risk of progression to polyarthritis and destruction. [55]

In JIA oligoarthritis, the outcome is favorable with early control of inflammation and prevention of uveitis; with "extend" therapy, biologics are more often required, but long-term function remains good with adherence to the strategy. Septic oligoarthritis carries the worst risk of joint destruction—the outcome depends on hours/days, not weeks. [56]

Table 6. Signs of high risk of adverse outcome

Scenario	What's alarming	What to do
PsA/pSpA	Frequent enthesitis/dactylitis, high activity	Early b/tsDMARD, treat-to-target
YIA	ANA+, young age, early uveitis	Frequent eye examination, early MTX/bio
Crystal	Frequent attacks, tophi	Hard urate concentration and titration
Septic	Fever, ↑CRP, rapid swelling	Puncture/AB immediately; repeat sanitation [57]

FAQ

• How many joints must be involved to call it oligoarthritis?

Up to four at a time. This is a pattern, not a diagnosis: next, we need to determine the cause - PsA/pSpA, reactive, crystalline, septic, etc. [58]

• Is it possible to avoid a puncture in case of acutely inflamed joint?

If there's even the slightest suspicion of infection, no: arthrocentesis with culture is mandatory, and if confirmed, immediate antibiotics and drainage are necessary. Missing septic arthritis can lead to joint destruction. [59]

• How is oligoarthritis treated in psoriasis?

Start with NSAIDs and local injections of GCS; if the effect is insufficient, csDMARDs for peripheral inflammation; if unsuccessful, biological or targeted therapy (TNF/IL-17/IL-23/JAK) using a treat-to-target strategy and taking into account concomitant skin/enthesitis/axis manifestations. [60]

• Does reactive arthritis always require antibiotics?

Antibiotics are indicated for proven active trigger infections (e.g., urogenital), especially chlamydial ones. If the source of infection has already been eliminated, long-term antibacterial therapy is ineffective; the focus should be on NSAIDs/CS, exercise therapy, and, if necessary, csDMARDs. [61]

• Which imaging modalities are "better" for early oligoarthritis?

X-ray is basic, but ultrasound and MRI are better at showing early synovitis, enthesitis and osteitis; this helps in making the diagnosis and assessing activity to select therapy. [62]

Table 7. Basic “starter kit” of examinations for suspected inflammatory oligoarthritis

Block	What to submit/do	For what
Blood	Complete blood count, CRP/ESR, RF, anti-CCP, uric acid, HLA-B27 (as indicated)	Inflammation, rule out RA, crystals/SpA
Infections	PCR/cultures (urogenital/stool)	Finding a trigger for reactive arthritis
Synovia	Puncture: WBC, Gram/culture, crystals, glucose/protein	Distinguish between sepsis/crystals/inflammation
Visualization	Basic X-ray; PD ultrasound; MRI (as indicated)	Early synovitis/enthesitis/osteitis, erosions [63]